Rome Therapeutics is a Cambridge, Massachusetts biotechnology company developing therapies that target the "repeatome" — the vast repetitive, non-coding regions of the human genome (the "dark genome," including LINE-1 and other transposable elements) implicated in cancer and autoimmune disease. - View it on GitHub